Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,696
Closed -$766K 51
2018
Q3
$766K Sell
3,696
-1,462
-28% -$288K 0.13% 81
2018
Q2
$952K Sell
5,158
-51
-1% -$9.02K 0.16% 86
2018
Q1
$888K Buy
5,209
+24
+0.5% +$4.41K 0.13% 102
2017
Q4
$901K Sell
5,185
-113
-2% -$20K 0.1% 110
2017
Q3
$987K Buy
5,298
+292
+6% +$51.7K 0.11% 101
2017
Q2
$862K Sell
5,006
-14
-0.3% -$2.28K 0.07% 119
2017
Q1
$824K Buy
5,020
+1,045
+26% +$174K 0.07% 119
2016
Q4
$581K Buy
+3,975
New +$598K 0.04% 158

Other funds holding AMGN

Forward Management's AMGN Position: Q4 2018 in Review

Forward Management sold out of Amgen (AMGN) in Q4 2018, closing a stake of 3,696 shares — an estimated $766K sold.

Forward Management first reported a position in AMGN in Q4 2016 and held it in 8 quarters. The position peaked at $987K in Q3 2017. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Forward Management reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • Forward Management sold 3,696 Amgen shares in Q4 2018, an estimated $766K.
  • Forward Management first reported a position in Amgen in Q4 2016 and held it in 8 quarters.
  • Forward Management's Amgen position peaked at $987K in Q3 2017.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Forward Management's 13F filing for Q4 2018, filed 1 Feb 2019.